David Nakar
Impact in
- Pharmaceutical Science top 5%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Molecular Medicine top 10%
Papers in
-
- Glycosylation and Glycoproteins Research 1
- Enzyme Catalysis and Immobilization 1
-
- Proteoglycans and glycosaminoglycans research 2
- Co-authors
- Amnon Sintov (2 shared papers)Abraham Rubinstein (2 shared papers)David L. Gutnick (2 shared papers)Yuval Shoham (3 shared papers)Edward A. Bayer (3 shared papers)Raphael Lamed (3 shared papers)Yoav Barak (2 shared papers)Adva Mechaly (2 shared papers)
In The Last Decade
David Nakar
8 papers receiving 424 citations
Peers
Comparison fields: 5 of 63
- Pharmaceutical Science 94
- Molecular Medicine 49
- Biotechnology 81
- Gastroenterology 46
- Endocrinology 19
Countries citing papers authored by David Nakar
This map shows the geographic impact of David Nakar's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by David Nakar with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites David Nakar more than expected).
Fields of papers citing papers by David Nakar
This network shows the impact of papers produced by David Nakar. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by David Nakar. The network helps show where David Nakar may publish in the future.
Co-authors
The 12 scholars most cited alongside David Nakar, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | 1992 | 100 | |
| 2 | 2005 | 98 | |
| 3 | 1992 | 86 | |
| 4 | 2003 | 64 | |
| 5 | 2001 | 45 | |
| 6 | 2004 | 35 | |
| 7 | 2004 | 16 | |
| 8 | 2004 | 2 |
About David Nakar
David Nakar is a scholar working on Molecular Biology, Cell Biology, Pollution, Pharmaceutical Science and Biomedical Engineering, having authored 8 papers that have together received 446 indexed citations. Recurring topics across this work include Advanced Drug Delivery Systems (2 papers), Proteoglycans and glycosaminoglycans research (2 papers), Microbial bioremediation and biosurfactants (2 papers), Biofuel production and bioconversion (2 papers), Pesticide and Herbicide Environmental Studies (1 paper), Glycosylation and Glycoproteins Research (1 paper), Enzyme Catalysis and Immobilization (1 paper) and Polysaccharides and Plant Cell Walls (1 paper). The work is most often cited by research in Pharmaceutical Science (94 citations), Molecular Medicine (49 citations), Biotechnology (81 citations), Gastroenterology (46 citations) and Endocrinology (19 citations). David Nakar has collaborated with scholars based in Israel and France. Frequent co-authors include Amnon Sintov, Abraham Rubinstein, David L. Gutnick, Yuval Shoham, Edward A. Bayer, Raphael Lamed, Yoav Barak, Adva Mechaly, Ely Morag and Henri‐Pierre Fierobe. Their work appears in journals such as Microbiology, Journal of Biological Chemistry, FEBS Letters, Journal of Bacteriology and International Journal of Pharmaceutics.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.